Eli Lilly Stock Jumps After Strong Earnings and Sales. Obesity Drugs Delivered.
Text size Analysts project that Mounjaro will be the best-selling drug of all time. Dreamstime Sales of Eli Lilly ‘s ...
Read more
Tag: new product
Excess weight-Decline Medicines Will Be Blockbusters. Here’s the Stock to Invest in.
Excess weight-Decline Drugs Will Be Blockbusters. Here’s the Inventory to Get.
Read more
Why Moderna Inventory Is Sliding In spite of Favourable Vaccines Update
Text sizing Moderna gave an update on its portfolio of vaccines. Getty Illustrations or photos Moderna claimed Tuesday an unbiased ...
Read more
CureVac Stock Just Bought Upgraded. It is Now a Competitor in mRNA Vaccines.
Textual content sizing CureVac inventory has surged given that reporting promising mRNA trial information on Jan. 6. Jeroen Jumelet/ANP/AFP through ...
Read more
AbbVie cuts earnings forecast due to milestone payments
AbbVie Inc. executives decreased their outlook for the quarter and yr in a filing with the Securities and Exchange Commission ...
Read more
Why Pfizer Is Pulling Back again on Exploration Into Unusual Condition, Gene Treatment
Pfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include the development of new ...
Read more
Two Biotech CEOs Indicted on Securities Fraud Costs
Two Biotech CEOs Indicted on Securities Fraud Charges
Read more
Moderna Soared on Information of Most cancers Vaccine. Why 1 Analyst Downgraded the Inventory.
Moderna inventory jumped by double digits Tuesday on constructive information about the company’s most cancers vaccine, but Chardan Funds Markets ...
Read more
Moderna Stock Will take Off on Most cancers Vaccine Information
Moderna stock shot up following Merck explained it is training an possibility to work on a customized most cancers vaccine ...
Read moreModerna Stock Takes Off on Cancer Vaccine Information
Moderna inventory shot up just after Merck explained it is performing exercises an choice to work on a customized most ...
Read more
